238.00 - 242.07
140.53 - 242.25
26.77M / 38.44M (Avg.)
25.64 | 9.39
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
15.66%
Net income growth above 1.5x META's 10.17%. David Dodd would see a clear bottom-line advantage if it is backed by stable operations.
11.65%
D&A growth well above META's 11.33%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
44.42%
Some yoy growth while META is negative at -17.82%. John Neff would see competitor possibly managing deferrals more aggressively for short-term advantage.
-18.04%
Negative yoy SBC while META is 16.57%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
398.66%
Slight usage while META is negative at -271.20%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-36.69%
Both yoy AR lines negative, with META at -147.72%. Martin Whitman would suspect an overall sector lean approach or softer demand.
46.98%
Inventory growth of 46.98% while META is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
308.82%
AP growth well above META's 144.49%. Michael Burry would be concerned about potential late payments or short-term liquidity strain relative to competitor.
739.72%
Growth well above META's 93.48%. Michael Burry would see a potential hidden liquidity or overhead issue overshadowing competitor's approach.
-213.05%
Negative yoy while META is 175.76%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
32.74%
Operating cash flow growth above 1.5x META's 6.39%. David Dodd would confirm superior cost control or stronger revenue-to-cash conversion.
3.91%
Some CapEx rise while META is negative at -27.80%. John Neff would see competitor possibly building capacity while we hold back expansions.
-255.61%
Negative yoy acquisition while META stands at 0.00%. Joel Greenblatt sees potential short-term cash advantage unless competitor’s deals yield big synergy.
-107.76%
Both yoy lines negative, with META at -95.19%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
132.31%
At 50-75% of META's 198.35%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
No Data
No Data available this quarter, please select a different quarter.
-16.01%
Both yoy lines negative, with META at -29.73%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.